Amlogenyx Inc.

SEC filing

Biotechnology · Novato, CA

Form D on EDGAR

Amount raised$10Msold at filing

Total offering$20M$10M still open

Investors in the raise2count reported to the SEC

FiledJul 9, 2026first sale Jul 1, 2026

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

JOHN PINIONExecutive Officer

CRAIG GORDONDirector

SUKUMAR NAGENDRANDirector

EMIL KAKKISExecutive Officer, Director

TED HUIZENGAExecutive Officer

Karah ParschauerExecutive Officer

Executive officers, directors and promoters as listed on the Form D.